Difficulty: Medium
Average Score: 77%
Practice
All of the following physiologic reactions are involved in the control of bleeding EXCEPT:
Correct answer
Quinidine
Rationale
In the context of pharmacological lifespan treatment and the control of bleeding, the correct answer is Quinidine. Quinidine is a Class IA antiarrhythmic drug, not involved in controlling bleeding.
Sotalol (Option B) is a beta-blocker with some antiarrhythmic properties, used in the management of various cardiac conditions, but it is not directly related to controlling bleeding. Propranolol (Option C) is also a beta-blocker, primarily used for hypertension and heart-related conditions, not for controlling bleeding. Verapamil (Option D) is a calcium channel blocker used in conditions like hypertension and angina, not for controlling bleeding.
Educationally, understanding the pharmacological actions of drugs is crucial for healthcare professionals to make informed decisions in patient care. In this scenario, knowing that Quinidine is a Class IA antiarrhythmic drug helps in distinguishing its role from other medications that do not directly impact bleeding control. By differentiating between these drugs, healthcare providers can ensure appropriate treatment strategies are implemented for patients requiring management of bleeding disorders.
Sotalol (Option B) is a beta-blocker with some antiarrhythmic properties, used in the management of various cardiac conditions, but it is not directly related to controlling bleeding. Propranolol (Option C) is also a beta-blocker, primarily used for hypertension and heart-related conditions, not for controlling bleeding. Verapamil (Option D) is a calcium channel blocker used in conditions like hypertension and angina, not for controlling bleeding.
Educationally, understanding the pharmacological actions of drugs is crucial for healthcare professionals to make informed decisions in patient care. In this scenario, knowing that Quinidine is a Class IA antiarrhythmic drug helps in distinguishing its role from other medications that do not directly impact bleeding control. By differentiating between these drugs, healthcare providers can ensure appropriate treatment strategies are implemented for patients requiring management of bleeding disorders.